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The title compound {systematic name: 4-[(E)-2-(3,5-dihy-
droxyphenyl)ethenyl]benzene-1,3-diol dihydrate}, C14H12O4 -
2H2O, a derivative of resveratrol, was isolated from mulberry.
The linking C C double bond has a trans conformation and
allows the formation of a conjugated system throughout the
molecule. The dihedral angle between the benzene rings is
9.39 (9) . In the crystal, molecules are connected into a three-
dimensional architecture through O—H   O hydrogen bonds
between hydroxy groups of oxyresveratrol and solvent water
molecules.
Related literature
For medicinal properties and the biological activity of
oxyresveratrol, see: Mongolsuk et al. (1957); Charoenlarp et al.
(1981, 1989); Zheng et al. (2010, 2011); Kim et al. (2002, 2004);
Shin et al. (1998); Lipipun et al. (2011); Galindo et al. (2011);
Sasivimolphan et al. (2009); Chuanasa et al. (2008); Likhitwi-
tayawuid (2008); Likhitwitayawuid et al. (2005, 2006); Liu et al.
(2009); Breuer et al. (2006); Chung et al. (2003); Chao et al.
(2008); Ban et al. (2006, 2008); Breuer et al. (2006); Andrabi et
al. (2004). For related structures, see: Piao et al. (2009); Qiu et






a = 6.6523 (5) A ˚
b = 9.2005 (9) A ˚
c = 11.5294 (8) A ˚
  = 72.533 (7) 
  = 78.686 (6) 
  = 79.651 (7) 
V = 654.51 (9) A ˚ 3
Z =2
Cu K  radiation
  = 0.95 mm
 1
T = 293 K
0.40   0.30   0.20 mm
Data collection
Agilent Xcalibur Onyx Nova
diffractometer
Absorption correction: multi-scan
(CrysAlis PRO; Agilent, 2010)
Tmin = 0.704, Tmax = 0.834
4145 measured reﬂections
2297 independent reﬂections












H atoms treated by a mixture of
independent and constrained
reﬁnement
 max = 0.50 e A ˚  3
 min =  0.44 e A ˚  3
Table 1
Hydrogen-bond geometry (A ˚ ,  ).
D—H   AD —H H   AD    AD —H   A
O1—H1   O4
i 0.84 1.90 2.7329 (18) 173
O2—H2   O6
ii 0.84 1.89 2.720 (2) 171
O3—H3A   O6
iii 0.84 1.97 2.8045 (19) 169
O4—H4   O5
iv 0.84 1.89 2.7259 (19) 170
O5—H5A   O1
i 0.89 (2) 1.90 (2) 2.7879 (19) 172 (2)
O5—H5B   O2
v 0.89 (2) 1.88 (2) 2.7449 (19) 161 (2)
O6—H6B   O2
ii 0.90 (3) 1.95 (3) 2.720 (2) 143 (4)
O6—H6C   O6
vi 0.90 (4) 1.87 (4) 2.7583 (19) 172 (5)
Symmetry codes: (i)  x; y þ 1; z þ 2; (ii)  x; y þ 2; z þ 1; (iii)
 x þ 2; y þ 1; z þ 1; (iv) x þ 1;y;z; (v) x þ 1;y   1;z; (vi)
 x þ 1; y þ 1; z þ 1.
Data collection: CrysAlis PRO (Agilent, 2010); cell reﬁnement:
CrysAlis PRO; data reduction: CrysAlis PRO; program(s) used to
solve structure: SHELXTL (Sheldrick, 2008); program(s) used to
reﬁne structure: SHELXTL; molecular graphics: SHELXTL; soft-
ware used to prepare material for publication: publCIF (Westrip,
2010).
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Oxyresveratrol from Mulberry as a dihydrate
Hui Deng, Xixin He, Yujuan Xu and Xiaopeng Hu
Comment 
Oxyresveratrol was firstly isolated from the heartwood of Artocarpus lakoocha Roxb as a abundant trans-tetrahydroxy-
stilbene (Mongolsuk et al., 1957). Oxyresveratrol is responsible for the anthelmintic activity of the traditional Thailand 
anthelmintic drug "Puag-Haad" prepared from A. lakoocha (Charoenlarp et al., 1989; Charoenlarp et al., 1981). Recent 
investigations have revealed several interesting bioactivities of oxyresveratrol, such as tyrosinase inhibitory activity 
(Zheng et al., 2011; Zheng et al., 2010; Kim et al., 2004; Kim et al., 2002; Shin et al., 1998), in vitro anti-viral activity 
(Lipipun et al., 2011; Galindo et al., 2011; Sasivimolphan et al., 2009; Chuanasa et al., 2008; Likhitwitayawuid et al., 
2006; Likhitwitayawuid et al., 2005), strong anti-oxidative and anti-inflammatory (Liu et al., 2009; Breuer et al., 2006; 
Chung et al., 2003), and neuroprotective properties (Chao et al., 2008; Ban et al., 2008; Ban et al., 2006; Breuer et al., 
2006; Andrabi et al., 2004). These medicinal properties indicate several areas of therapeutic potential for oxyresveratrol 
and the compound has been recommended as a drug candidate for the treatment of neurodegenerative disorders (Breuer 
et al., 2006; Andrabi et al., 2004) and a skin-whitening agent in cosmetic preparations (Likhitwitayawuid, 2008). 
Mulberry (Morus alba L.) is a medicinal plant in east Asia. Its branch, leaf, ripe fruit and root bark are well known 
traditional Chinese drugs and contain a large amounts of trans-hydroxystilbenes such as mulberroside A, phaponticin, 
phapontigenin, resveratrol, pterostilbene, piceatannol, piceid, astringin, kuwanon Y, kuwanon Z, oxyresveratrol and its 
derivatives (Qiu et al., 1996; Hano et al., 1986; Piao et al., 2009). In this paper, we isolated oxyresveratrol from mulberry 
(Morus alba L.) and report the structure of oxyresveratrol dihydrate.
In the title compound (Fig. 1), the benzene rings form a dihedral angle of 9.39 (9)°. The presence of the trans C═C 
double bond allows the formation of a conjugated system, strongly stabilized through π-electron delocalization. The 
trans-double bond is the same as found in similar structures (Piao et al., 2009; Qiu et al., 1996; Hano et al., 1986). The 
molecules of the oxyresveratrol are connected into a three-dimensional architecture through O—H—O hydrogen bonds 
formed between its hydroxyl group and the solvent water molecules (Fig. 2 and Table 1).
Experimental 
The dried root bark of Morus alba L. (1 kg) was powdered and extracted with 95% ethanol at room temperature for 48 h. 
After removal of the solvent under reduced pressure, a brown extract was suspended with water, and sequentially 
partitioned with petroleum ether, acetyl acetate and n-butanol. The acetyl acetate extract (9 g) was subjected to column 
chromatography on silica gel (200–300 mesh) with increasing concentrations of ethyl acetate in petroleum ether. 
Oxyresveratrol was afforded from the fraction (petroleum ether-ethyl acetate 6/4, v/v). The title compound was colourless 
to light-yellow crystal with M.pt: 474–476 K,. Crystals suitable for X-ray analysis were obtained by slow evaporation 
from its chloroform–methanol (4/1, v/v) solution. 1H NMR (400 MHz, MeOD) δ 7.33 (d, J = 9.2 Hz, 1H), 7.27 (d, J = 
16.5 Hz, 1H), 6.82 (d, J = 16.4 Hz,1H), 6.46 (d, J = 2.1 Hz, 2H), 6.34 – 6.32 (m, 1H), 6.31 (s, 1H), 6.15 (t, J = 2.2 Hz, 
1H); O—H not observed.supplementary materials
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Refinement 
The hydroxy- and C-bound H-atoms were placed in calculated positions [O—H = 0.84 Å, Uiso(H) = 1.5Ueq(O); C—H = 
0.95 Å, Uiso(H) = 1.2Ueq(C)] and were included in the refinement in the riding model approximation. The water-H atoms 
were refined with O—H = 0.90±0.01 Å, and with Uiso(H) = 1.5Ueq(O). The O6-water molecule was found to be 
disordered over three positions, one with full weight, the others with 0.5 site occupancy factors.
Computing details 
Data collection: CrysAlis PRO (Agilent, 2010); cell refinement: CrysAlis PRO (Agilent, 2010); data reduction: CrysAlis 
PRO (Agilent, 2010); program(s) used to solve structure: SHELXTL (Sheldrick, 2008); program(s) used to refine 
structure: SHELXTL (Sheldrick, 2008); molecular graphics: SHELXTL (Sheldrick, 2008); software used to prepare 
material for publication: publCIF (Westrip, 2010).
Figure 1
A view of the molecular structure of compound (I). The displacement ellipsoids are at the 50% probability level and H 






Hall symbol: -P 1
a = 6.6523 (5) Å
b = 9.2005 (9) Å
c = 11.5294 (8) Å
α = 72.533 (7)°
β = 78.686 (6)°
γ = 79.651 (7)°
V = 654.51 (9) Å3
Z = 2
F(000) = 296
Dx = 1.422 Mg m−3
Cu Kα radiation, λ = 1.54178 Å
Cell parameters from 2627 reflections
θ = 4.1–71.3°
µ = 0.95 mm−1
T = 293 K
Block, colourless
0.40 × 0.30 × 0.20 mmsupplementary materials
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Data collection 
Agilent Xcalibur Onyx Nova 
diffractometer
Radiation source: Nova (Cu) X-ray Source
Mirror monochromator
Detector resolution: 8.2417 pixels mm-1
ω scans
Absorption correction: multi-scan 
(CrysAlis PRO; Agilent, 2010)
Tmin = 0.704, Tmax = 0.834
4145 measured reflections
2297 independent reflections
2002 reflections with I > 2σ(I)
Rint = 0.022













Primary atom site location: structure-invariant 
direct methods
Secondary atom site location: difference Fourier 
map
Hydrogen site location: inferred from 
neighbouring sites
H atoms treated by a mixture of independent 
and constrained refinement
w = 1/[σ2(Fo
2) + (0.081P)2 + 0.176P] 




Δρmax = 0.50 e Å−3
Δρmin = −0.44 e Å−3
Special details 
Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full 
covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and 
torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. 
An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes.
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, 
conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > σ(F2) is used 
only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 
are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger.
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2) 
xy z U iso*/Ueq Occ. (<1)
C1 −0.1126 (3) 0.9054 (2) 0.76812 (16) 0.0253 (4)
C2 −0.2896 (3) 0.8772 (2) 0.85658 (16) 0.0251 (4)
C3 −0.4773 (3) 0.9699 (2) 0.84350 (16) 0.0260 (4)
H3 −0.5945 0.9490 0.9051 0.031*
C4 −0.4925 (3) 1.0933 (2) 0.73988 (17) 0.0270 (4)
C5 −0.3191 (3) 1.1277 (2) 0.65217 (18) 0.0304 (4)
H5 −0.3286 1.2143 0.5825 0.036*
C6 −0.1329 (3) 1.0347 (2) 0.66730 (17) 0.0291 (4)
H6 −0.0149 1.0594 0.6073 0.035*
C7 0.0785 (3) 0.7976 (2) 0.78124 (16) 0.0265 (4)
H7 0.0724 0.7073 0.8482 0.032*
C8 0.2599 (3) 0.8143 (2) 0.70802 (17) 0.0266 (4)
H8 0.2682 0.9072 0.6438 0.032*
C9 0.4478 (3) 0.7025 (2) 0.71754 (16) 0.0241 (4)
C10 0.6184 (3) 0.7319 (2) 0.62552 (16) 0.0258 (4)
H10 0.6122 0.8242 0.5605 0.031*supplementary materials
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C11 0.7979 (3) 0.6264 (2) 0.62855 (16) 0.0257 (4)
C12 0.8084 (3) 0.4895 (2) 0.72244 (17) 0.0273 (4)
H12 0.9292 0.4163 0.7238 0.033*
C13 0.6385 (3) 0.4623 (2) 0.81404 (16) 0.0260 (4)
C14 0.4594 (3) 0.5662 (2) 0.81327 (16) 0.0257 (4)
H14 0.3454 0.5451 0.8771 0.031*
O1 −0.27079 (18) 0.75380 (14) 0.95877 (12) 0.0298 (3)
H1 −0.3888 0.7321 0.9944 0.045*
O2 −0.68101 (19) 1.17941 (15) 0.72308 (13) 0.0352 (4)
H2 −0.6634 1.2691 0.6802 0.053*
O3 0.95691 (19) 0.66150 (15) 0.53537 (12) 0.0316 (3)
H3A 1.0617 0.5971 0.5509 0.047*
O4 0.64072 (19) 0.32934 (15) 0.90904 (12) 0.0330 (4)
H4 0.7589 0.2786 0.9044 0.049*
O5 0.01297 (19) 0.14910 (15) 0.92354 (12) 0.0318 (3)
H5A 0.085 (3) 0.187 (3) 0.963 (2) 0.048*
H5B 0.095 (3) 0.148 (3) 0.8524 (14) 0.048*
O6 0.67051 (19) 0.52209 (15) 0.40983 (12) 0.0300 (3)
H6A 0.637 (4) 0.490 (3) 0.3506 (17) 0.045*
H6B 0.701 (7) 0.618 (2) 0.394 (4) 0.045* 0.50
H6C 0.565 (6) 0.513 (6) 0.472 (3) 0.045* 0.50
Atomic displacement parameters (Å2) 
U11 U22 U33 U12 U13 U23
C1 0.0192 (9) 0.0256 (9) 0.0278 (9) −0.0011 (7) −0.0025 (7) −0.0043 (7)
C2 0.0202 (8) 0.0243 (9) 0.0270 (9) −0.0018 (6) −0.0028 (7) −0.0025 (7)
C3 0.0182 (8) 0.0268 (9) 0.0285 (9) −0.0011 (7) 0.0012 (7) −0.0051 (7)
C4 0.0187 (8) 0.0261 (9) 0.0322 (9) 0.0029 (7) −0.0031 (7) −0.0057 (7)
C5 0.0249 (9) 0.0280 (9) 0.0300 (9) 0.0003 (7) −0.0011 (7) 0.0003 (7)
C6 0.0190 (8) 0.0307 (10) 0.0301 (9) −0.0006 (7) 0.0017 (7) −0.0023 (8)
C7 0.0220 (9) 0.0234 (9) 0.0295 (9) 0.0010 (7) −0.0047 (7) −0.0023 (7)
C8 0.0217 (9) 0.0224 (9) 0.0314 (9) 0.0006 (7) −0.0037 (7) −0.0034 (7)
C9 0.0204 (8) 0.0234 (9) 0.0280 (9) −0.0009 (6) −0.0029 (7) −0.0080 (7)
C10 0.0211 (9) 0.0239 (9) 0.0290 (9) −0.0010 (7) −0.0025 (7) −0.0042 (7)
C11 0.0195 (8) 0.0280 (9) 0.0273 (9) −0.0042 (7) −0.0002 (7) −0.0056 (7)
C12 0.0182 (8) 0.0271 (9) 0.0318 (10) 0.0018 (7) −0.0029 (7) −0.0043 (7)
C13 0.0205 (8) 0.0266 (9) 0.0269 (9) −0.0025 (7) −0.0021 (7) −0.0029 (7)
C14 0.0175 (8) 0.0303 (9) 0.0261 (9) −0.0009 (7) 0.0003 (7) −0.0066 (7)
O1 0.0184 (6) 0.0289 (7) 0.0309 (7) −0.0003 (5) −0.0007 (5) 0.0049 (5)
O2 0.0210 (7) 0.0280 (7) 0.0427 (8) 0.0060 (5) −0.0017 (6) 0.0036 (6)
O3 0.0180 (6) 0.0314 (7) 0.0341 (7) 0.0013 (5) 0.0036 (5) 0.0003 (5)
O4 0.0189 (6) 0.0316 (7) 0.0333 (7) 0.0035 (5) 0.0022 (5) 0.0059 (6)
O5 0.0238 (7) 0.0339 (7) 0.0329 (7) 0.0019 (5) −0.0046 (5) −0.0050 (6)
O6 0.0239 (7) 0.0299 (7) 0.0343 (8) −0.0026 (5) −0.0023 (5) −0.0078 (6)supplementary materials
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Geometric parameters (Å, º) 
C1—C6 1.399 (3) C10—C11 1.396 (2)
C1—C2 1.405 (2) C10—H10 0.9500
C1—C7 1.468 (2) C11—O3 1.359 (2)
C2—O1 1.377 (2) C11—C12 1.394 (3)
C2—C3 1.387 (2) C12—C13 1.389 (2)
C3—C4 1.385 (3) C12—H12 0.9500
C3—H3 0.9500 C13—O4 1.376 (2)
C4—O2 1.373 (2) C13—C14 1.387 (2)
C4—C5 1.391 (3) C14—H14 0.9500
C5—C6 1.382 (3) O1—H1 0.8400
C5—H5 0.9500 O2—H2 0.8400
C6—H6 0.9500 O3—H3A 0.8400
C7—C8 1.335 (3) O4—H4 0.8400
C7—H7 0.9500 O5—H5A 0.890 (10)
C8—C9 1.469 (2) O5—H5B 0.893 (10)
C8—H8 0.9500 O6—H6A 0.897 (10)
C9—C10 1.397 (2) O6—H6B 0.894 (10)
C9—C14 1.402 (2) O6—H6C 0.896 (10)
C6—C1—C2 116.74 (16) C10—C9—C8 118.39 (16)
C6—C1—C7 123.22 (15) C14—C9—C8 122.38 (15)
C2—C1—C7 119.97 (16) C11—C10—C9 120.38 (16)
O1—C2—C3 120.45 (15) C11—C10—H10 119.8
O1—C2—C1 117.62 (15) C9—C10—H10 119.8
C3—C2—C1 121.93 (16) O3—C11—C12 122.21 (15)
C4—C3—C2 119.39 (16) O3—C11—C10 117.25 (16)
C4—C3—H3 120.3 C12—C11—C10 120.51 (16)
C2—C3—H3 120.3 C13—C12—C11 118.52 (16)
O2—C4—C3 119.43 (15) C13—C12—H12 120.7
O2—C4—C5 120.23 (16) C11—C12—H12 120.7
C3—C4—C5 120.32 (16) O4—C13—C14 117.15 (15)
C6—C5—C4 119.44 (17) O4—C13—C12 120.98 (15)
C6—C5—H5 120.3 C14—C13—C12 121.86 (16)
C4—C5—H5 120.3 C13—C14—C9 119.49 (15)
C5—C6—C1 122.11 (16) C13—C14—H14 120.3
C5—C6—H6 118.9 C9—C14—H14 120.3
C1—C6—H6 118.9 C2—O1—H1 109.5
C8—C7—C1 126.20 (16) C4—O2—H2 109.5
C8—C7—H7 116.9 C11—O3—H3A 109.5
C1—C7—H7 116.9 C13—O4—H4 109.5
C7—C8—C9 126.05 (17) H5A—O5—H5B 104 (2)
C7—C8—H8 117.0 H6A—O6—H6B 119 (4)
C9—C8—H8 117.0 H6A—O6—H6C 109 (4)
C10—C9—C14 119.21 (15) H6B—O6—H6C 106 (5)
C6—C1—C2—O1 −177.63 (15) C1—C7—C8—C9 −176.59 (16)
C7—C1—C2—O1 5.2 (3) C7—C8—C9—C10 173.61 (18)
C6—C1—C2—C3 1.8 (3) C7—C8—C9—C14 −4.5 (3)supplementary materials
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C7—C1—C2—C3 −175.39 (16) C14—C9—C10—C11 0.3 (3)
O1—C2—C3—C4 −179.97 (16) C8—C9—C10—C11 −177.84 (16)
C1—C2—C3—C4 0.7 (3) C9—C10—C11—O3 179.27 (15)
C2—C3—C4—O2 175.96 (16) C9—C10—C11—C12 0.9 (3)
C2—C3—C4—C5 −2.6 (3) O3—C11—C12—C13 −179.80 (16)
O2—C4—C5—C6 −176.49 (17) C10—C11—C12—C13 −1.5 (3)
C3—C4—C5—C6 2.1 (3) C11—C12—C13—O4 −179.83 (16)
C4—C5—C6—C1 0.5 (3) C11—C12—C13—C14 1.0 (3)
C2—C1—C6—C5 −2.3 (3) O4—C13—C14—C9 −179.06 (15)
C7—C1—C6—C5 174.73 (18) C12—C13—C14—C9 0.2 (3)
C6—C1—C7—C8 6.8 (3) C10—C9—C14—C13 −0.8 (3)
C2—C1—C7—C8 −176.28 (18) C8—C9—C14—C13 177.25 (16)
Hydrogen-bond geometry (Å, º) 
D—H···AD —H H···AD ···AD —H···A
O1—H1···O4i 0.84 1.90 2.7329 (18) 173
O2—H2···O6ii 0.84 1.89 2.720 (2) 171
O3—H3A···O6iii 0.84 1.97 2.8045 (19) 169
O4—H4···O5iv 0.84 1.89 2.7259 (19) 170
O5—H5A···O1i 0.89 (2) 1.90 (2) 2.7879 (19) 172 (2)
O5—H5B···O2v 0.89 (2) 1.88 (2) 2.7449 (19) 161 (2)
O6—H6B···O2ii 0.90 (3) 1.95 (3) 2.720 (2) 143 (4)
O6—H6C···O6vi 0.90 (4) 1.87 (4) 2.7583 (19) 172 (5)
Symmetry codes: (i) −x, −y+1, −z+2; (ii) −x, −y+2, −z+1; (iii) −x+2, −y+1, −z+1; (iv) x+1, y, z; (v) x+1, y−1, z; (vi) −x+1, −y+1, −z+1.